Jubilant Ingrevia Share Price

NSE
JUBLINGREA •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Jubilant Ingrevia
Jubilant Ingrevia Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Jubilant Ingrevia Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
26.07% Fall from 52W High
-0.7
Dividend yield 1yr %
Above industry Median
0.8

Jubilant Ingrevia Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Jubilant Ingrevia Quarterly Revenue

Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
1056.77 Cr
1045.24 Cr
1024.34 Cr
1074.44 Cr
966.4 Cr

Jubilant Ingrevia Yearly Revenue

Mar 2024Mar 2023Mar 2022Mar 2021
4171.1 Cr
4806.06 Cr
4980.85 Cr
686.73 Cr

Jubilant Ingrevia Quarterly Net Profit/Loss

Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
69.37 Cr
59 Cr
48.66 Cr
29.3 Cr
38.53 Cr

Jubilant Ingrevia Yearly Net Profit/Loss

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
182.87 Cr
307.53 Cr
476.76 Cr
54.36 Cr
-0.17 Cr
Jubilant Ingrevia Result Highlights
  • Jubilant Ingrevia Ltd reported a 1.0% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a growth of 9.3%.

  • Its expenses for the quarter were down by 0.5% QoQ and up 5.5% YoY.

  • The net profit increased 17.6% QoQ and increased 79.9% YoY.

  • The earnings per share (EPS) of Jubilant Ingrevia Ltd stood at 4.4 during Q3FY25.

    Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

Jubilant Ingrevia shareholding Pattern

Promoter
51.5%
Foreign Institutions
7.1%
Mutual Funds
14.1%
Domestic Institutions
15.9%
Public
24.8%
Promoter
51.5%
Foreign Institutions
6.9%
Mutual Funds
13.9%
Domestic Institutions
16%
Public
24.9%
Promoter
51.5%
Foreign Institutions
7.2%
Mutual Funds
12.7%
Domestic Institutions
15.5%
Public
25.1%
Promoter
51.5%
Foreign Institutions
6.6%
Mutual Funds
10.6%
Domestic Institutions
14%
Public
27.1%
Promoter
51.5%
Foreign Institutions
6.6%
Mutual Funds
10.2%
Domestic Institutions
13.6%
Public
27.5%
Promoter
51.5%
Foreign Institutions
6.4%
Mutual Funds
9.1%
Domestic Institutions
11.1%
Public
30.2%

Jubilant Ingrevia Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
16
5Day EMA
672.00
10Day EMA
670.20
12Day EMA
669.00
20Day EMA
666.40
26Day EMA
666.20
50Day EMA
673.10
100Day EMA
685.30
200Day EMA
670.20
5Day SMA
678.60
10Day SMA
675.90
20Day SMA
656.70
30Day SMA
666.80
50Day SMA
662.30
100Day SMA
711.50
150Day SMA
717.20
200Day SMA
701.10
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
164724 Rs
345424 Rs
Week Rs
168207 Rs
638891 Rs
Month Rs
114779 Rs
353921 Rs
Resistance & Support
662.58
Pivot
Resistance
First Resistance
677.37
Second Resistance
700.48
Third Resistance
715.27
Support
First Support
639.47
Second support
624.68
Third Support
601.57
Relative Strength Index
47.17
Money Flow Index
73.80
MACD
2.81
MACD Signal
0.02
Average True Range
34.56
Average Directional Index
12.29
Rate of Change (21)
-4.97
Rate of Change (125)
-4.46

Jubilant Ingrevia Latest News

28 APR 2025 | Monday

Jubilant Ingrevia Ltd - 543271 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

28 APR 2025 | Monday

Jubilant Ingrevia Ltd - 543271 - Board Meeting Intimation for 1. Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Year Ended March 31, 2025; And 2. Recommendation Of Final Dividend For The Financial Year Ended March 31, 2025, Ifany.

25 APR 2025 | Friday

Jubilant Ingrevia Ltd - 543271 - Updates On Acquisition

View More

Jubilant Ingrevia Company background

Founded in: 2019
Managing director: Mr. Deepak Jain
Jubilant Ingrevia Limited (Formerly known as Jubilant LSI Limited) was incorporated as a Public Limited Company on 23 October 2019 in Uttar Pradesh. The name of Company was changed from Jubilant LSI Limited to Jubilant Ingrevia Limited effective October 16, 2020. The Company is a global integrated Life Science products and Innovative Solutions provider serving Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with customised products and solutions that are innovative, costeffective and conforming to excellent quality standards. The Company is a part of the Jubilant Bhartia Group, a diversified global conglomerate founded by Mr. Shyam S. Bhartia and Mr. Hari S. Bhartia. Today, the Group has a strong presence in diverse sectors like Pharmaceuticals, Contract Research and Development Services, Proprietary Novel Drugs, Life Science Ingredients, Agri Products, Performance Polymers, Food Service (QSR), Food, Auto, Consulting in Aerospace and Oilfield Services. The Group has four flagships companies listed on Indian Stock Exchanges Jubilant Ingrevia Limited, Jubilant Pharmova Limited, Jubilant FoodWorks Limited and Jubilant Industries Limited. The Companys stateoftheart manufacturing facilities across India offer a range of products and solutions that are innovative, costeffective and quality driven. It established itself as a single point solution for CDMO services for global Pharmaceutical and Agrochemical companies. It is at present across the value chain like Route design, Process Development, Process Optimisation, Scaleup and Commercial Manufacturing of Advance Intermediates for Pharma and Agro and Actives for Agrochemicals. It is a leading supplier of Ethanol to Oil Marketing Companies (OMCs) for Ethanol Blending Programme (EBP) among standalone distilleries in India. The Company is engaged in manufacturing and supply of speciality intermediates, nutrition health solutions and life science chemicals through five manufacturing facilities in India. It offers broad portfolio of high quality ingredient that find application in a wide range of industries. It serves more than 1400 customers in more than 60 countries across the world. The portfolio of the Company is extended to custom research and manufacturing for pharmaceutical and agrochemical customers on an exclusive basis. The business focuses on three core segments Speciality Chemicals, Nutrition and Health Solutions and Life Science Chemicals. The Company offer a range of products including straight Nutritional Ingredients like Vitamin B3, Picolinates to premix solutions for animal and human nutrition. The Life Science Chemicals and Speciality Chemicals segments provide complete backward integration giving competitive edge over competitors. The Company is the global largest producer of Niacinamide and amongst Global top two manufacturers of Vitamin B3 and Indias largest manufacturer of Vitamin B4. The Company is a Partner of Choice for more than 400 global customers. It has also embarked on the manufacturing of herbal range of products for animal feed under the brand Phytoshield. The Life Science Ingredients (LSI) business of Jubilant Pharmova Limited was demerged into the Company, (Jubilant Ingrevia Limited) through the Scheme of Amalgamation effective from February 1, 2021. Pursuant to Composite Scheme of Arrangement, 5 subsidiary companies of Jubilant Pharmova Limited namely, Jubilant Infrastructure Limited, Jubilant Life Sciences (USA) Inc., Jubilant Life Sciences International Pte. Limited, Jubilant Life Sciences (Shanghai) Limited and Jubilant Life Sciences NV became subsidiaries of the Company effective from the said date.During FY 202223, the Company acquired 37.98% of equity share capital of Mister Veg Foods Private Limited (MVFPL) effective March 16, 2023. It commissioned the 25,000 TPA New Acetic Anhydride Plant in Bharuch, Gujarat.
Read More

Jubilant Ingrevia FAQs

Jubilant Ingrevia share price is ₹657.25 in NSE and ₹658.25 in BSE as on 29/4/2025.

Jubilant Ingrevia share price in the past 1-year return was 20.42. The Jubilant Ingrevia share hit a 1-year low of Rs. 462.3 and a 1-year high of Rs. 885.

The market cap of Jubilant Ingrevia is Rs. 10420.97 Cr. as of 29/4/2025.

The PE ratios of Jubilant Ingrevia is 50.94 as of 29/4/2025.

The PB ratios of Jubilant Ingrevia is 4.52 as of 29/4/2025

The Mutual Fund Shareholding in Jubilant Ingrevia was 14.1% at the end of 29/4/2025.

You can easily buy Jubilant Ingrevia shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Please be aware that Jubilant Ingrevia stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -